Prevalence and predictors of non‐alcoholic fatty liver disease (NAFLD) and metabolic dysfunction‐associated fatty liver disease (MAFLD) in Indian women with polycystic ovarian syndrome

Documenti analoghi

• Letter to “Prevalence and predictors of non‐alcoholic fatty liver disease ( NAFLD ) and metabolic dysfunction‐associated fatty liver disease ( MAFLD ) in Indian women with polycystic ovarian syndrome”
  di: Francis de Zegher, et al.
  Pubblicazione: (2025)
• Role of the mitophagy‐apoptosis axis in the pathogenesis of polycystic ovarian syndrome
  di: Hiroshi Kobayashi, et al.
  Pubblicazione: (2024)
• Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH ‐ MoM and ovarian sensitivity index
  di: Yoo Ra Ko, et al.
  Pubblicazione: (2024)
• Evaluation of expression of amino acid and fatty acid metabolic transporters in the placenta of pregnant women with glucose intolerance
  di: Toshihide Sakuragi, et al.
  Pubblicazione: (2024)
• Increased miscarriage rate is associated with at least four components of metabolic syndrome in women with polycystic ovary syndrome undergoing in vitro fertilization or intracytoplasmic sperm injection embryo transfer cycle
  di: Ziyi Dai, et al.
  Pubblicazione: (2024)